APOE and dementia: Meanwhile, out-of-insurance testing or direct-to-consumer (DTC) testing of the APOE genotype has been available (Pavarini et al. 2021), especially for those who are cognitively normal but are worried about their risk of dementia to prepare in advance before developing dementia.